中國醫藥大學醫學系學士1999~2006

和信治癌中心醫院 內科部 住院醫師 2006~2009年
和信治癌中心醫院 血液與腫瘤內科部 專研醫師 2009~2012年

中華民國內科醫學會
中華民國癌症醫學會
中華民國血液病醫學會
中華民國血液及骨髓移植醫學會
台灣癌症安寧緩和醫學會

• Durable Response to Lapatinib Plus Capecitabine in Trastuzumab – Resistant HER2 Over‐expressing Metastatic Breast Cancer; Peng‐Yu Chen, Mei‐Ching Liu, Chii‐Ming Chen, Mei‐Hua Tsou, Lin‐Chieh Huang, Chu‐Yun Chen; J. Cancer Res. Pract. 27(3),123‐132, 2011.
• Local treatment of breast cancer in de novo stage IV breast cancer patients. Peng‐Yu Chen, Skye H Hong‐Chun Cheng; J Clin Oncol 30, 2012 (suppl; abstr e11526).
• The prognostic value of microarray ERBB2 gene and immunohistochemical stain/FISH of HER2 for early breast cancer patients. P.Y. Chen, S.H.C. Cheng, B.L. Yu, C.M. Chen; Eur J Cancer. Sep 2015, Volume 51, Supplement 3, Page S303.
• Efficacy and Safety of Nivolumab Therapy for Advanced NSCLC in the Expanded Access Named Patient Program in Taiwan. Bin-Chi Liao, Chi-Lu Chiang, Peng-Yu Chen, Yi-Cheng Shen, Wei-Chun Chen, Jen-Yu Hung, Kun-Ming Rau, Chun-Liang Lai, Chao-Hsun Chen, Yu-Hsuan Kuo, Ying-Huang Tsai, Sheng-Cheng Wu, Chih-Bin Lin, Yu-Feng Wei, Ming-Fang Wu, Shih-Ming Tsao, Thomas Chang-Yao Tsao, Ching-Liang Ho, Yin-Hsun Feng, Chao-Jung Tsao, Meng-Chih Lin, Inn-Wen Chong, Te-Chun Hsia, Nei-Min Chu, Yuh-Min Chen, Chong-Jen Yu, James Chih-Hsin Yang; Journal of Thoracic Oncology Volume 12, Issue 11, Supplement 2, November 2017, Pages S2425-S2426.